Binary Test Reagent System for Analyte Measurement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing test reagents using insoluble carrier particles for measuring analytes in biological samples face issues of self-agglutination during storage and non-specific agglutination during measurement, particularly due to variations in ionic strength and contamination.

Innovation Solution

A binary solution system is employed, where a buffer solution (Solution A) with an electric conductivity of at least 30 ms/cm is mixed with a particle suspension (Solution B) having an electric conductivity of no more than 6.5 ms/cm immediately before measurement, preventing self-agglutination during storage and non-specific agglutination during analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If insoluble carrier particles are suspended in a solvent with low ionic strength (low electric conductivity), then good dispensability and sensitivity are achieved, but non-specific agglutination occurs due to ion contamination from biological samples

Engineering Contradiction:
ImprovesensitivityVSAvoidnon-specific agglutination
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The test reagent is divided into two separate solutions: Solution A (buffer solution with high electric conductivity ≥30 ms/cm) and Solution B (particle suspension with low electric conductivity ≤6.5 ms/cm). This segmentation allows each component to maintain its optimal properties independently, preventing non-specific agglutination while preserving sensitivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Solution A acts as an intermediary medium that modifies the ionic environment. By mixing Solution A with Solution B immediately before measurement, the buffer solution creates a controlled high-conductivity environment that prevents non-specific agglutination caused by ion contamination from biological samples.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If insoluble carrier particles are suspended in a solvent with high ionic strength (high electric conductivity), then self-agglutination is prevented during storage, but self-agglutination occurs during long-term storage for several days or months

Engineering Contradiction:
Improvestorage stabilityVSAvoidstorage duration
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The reagent system is segmented into two separate solutions stored independently. Solution B (particle suspension) is stored separately in a low-conductivity environment that prevents self-agglutination during long-term storage, while Solution A (buffer solution) is stored separately. This segmentation resolves the contradiction between storage stability and storage duration.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The two solutions are prepared and stored in advance in their respective optimal conditions (Solution B in low-conductivity medium for stability, Solution A in high-conductivity buffer), and then mixed immediately before measurement. This preliminary preparation allows long-term storage without self-agglutination while maintaining measurement performance.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If additives (polyethylene glycol or guanidine) are used to increase reagent sensitivity, then sensitivity is improved, but electric conductivity increases causing non-specific agglutination

Engineering Contradiction:
ImprovesensitivityVSAvoidnon-specific agglutination
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The system separates the particle suspension (Solution B) from the buffer medium (Solution A), allowing sensitivity optimization in Solution B without adding conductive additives, while Solution A provides the necessary ionic environment. This segmentation eliminates the need to add sensitivity-enhancing additives that would increase conductivity and cause non-specific agglutination.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach ensures accurate measurement of analytes by preventing self-agglutination during storage and minimizing non-specific agglutination during measurement, maintaining reagent stability and sensitivity.

Implementation Method 1

making the particle suspension with lower electric conductivity than a specific value, and making the buffer solution with higher electric conductivity than a specific value which is higher than the buffer solution normally employed in test reagents

Methodology Applied
Scientific EffectElectric conductivity control: Conduction (electrical)

Implementation Method 2

utilizing the level of agglutination by particle suspension which suspends insoluble carrier particles carrying a substance for capturing the analyte

Methodology Applied
Scientific EffectImmunological reaction: Absorption (physical)

Data Source

PatentUS9250235B2Test reagent, and method for measuring analyte in test sample using same
Publication Date: 2016.02.02 DENKA CO LTD
  • US9250235B2 patent drawing
  • US9250235B2 patent drawing
  • US9250235B2 patent drawing

AI summary

Object: To provide a test reagent for the analyte in a test sample, utilizing the level of agglutination of a particle suspension which suspend insoluble carrier particles carrying a substance for capturing the analyte as an indicator, which reagent does not undergo self-agglutination during storage, and which non-specific agglutination rarely occurs during measurement, as well as to provide a method for the analyte to be measured in a test sample. Means for Solution: The test reagent for the analyte comprises at least a Solution A which is a buffer solution having an electric conductivity of not less than 30 ms/cm; and a Solution B having an electric conductivity of not more than 6.5 ms/cm, the Solution B being a particle suspension which suspends particles which are insoluble carrier particles carrying a substance for capturing the analyte.